Results 151 to 160 of about 40,497 (266)
Remediation Journal, Volume 36, Issue 2, Spring 2026.ABSTRACT This review synthesizes current research on the phytoremediation potential of industrial hemp (Cannabis sativa L.) for heavy metals, including arsenic, aluminium, mercury, copper, lead, cadmium, nickel, and zinc, as well as per‐ and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.” A structured and transparent ...
Omid Ansari, Luca De Prato
wiley +1 more source
Transcriptomic dissection of floral identity and trichome-derived metabolite pathways in Cannabis sativa L. [PDF]
PlantaBarbosa-Xavier K, Venancio TM.
europepmc +1 more source
Glia, Volume 74, Issue 9, September 2026.Proinflammatory activation reorganizes microglial A2A and CB2 receptors, promoting their incorporation into stable heteromers and blocking agonist‐induced redistribution. The results reveal those heteromers as potential therapeutic targets in inflammatory contexts.
Rafael Franco +4 more
wiley +1 more source
Genetic architecture of phenological, morphological, and phytochemical traits in Cannabis landraces. [PDF]
Plant GenomeBabaei M, Torkamaneh D.
europepmc +1 more source
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.A case series studying outcomes up to 18 months in autistic patients from the UK Medical Cannabis Registry. ABSTRACT Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with distressed behaviors and psychological challenges.
Arushika Aggarwal +17 more
wiley +1 more source
Nutritive Value and Cannabinoid Potency of Diverse Hemp (<i>Cannabis sativa</i> L.) Varieties Grown under Different Light Conditions and Harvested across Multiple Time Points as a Possible Feed Source for Livestock. [PDF]
J Agric Food ChemDuringer JM +9 more
europepmc +1 more source
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi +2 more
wiley +1 more source
Hierarchical Chemotaxonomic Differentiation in Cannabis Chemovars Using Quantitative HPLC Cannabinoid Profiling and Multivariate Chemometrics. [PDF]
Plants (Basel)Mayong A +3 more
europepmc +1 more source
United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.ABSTRACT Background Data on the global prevalence of alarm features in the general population and among individuals with disorders of gut–brain interaction (DGBI) are limited. Methods We analysed data from the Rome Foundation Global Epidemiology Study to estimate the prevalence of fourteen self‐reported alarm features in the global population and among
Jessica Sjölund +7 more
wiley +1 more source